Cite

    Ali, H., Dariush, A., Provenzano, E., Bardwell, H., Abraham, J., Iddawela, M., Vallier, A., Hiller, L., Dunn, J., Bowden, S., Hickish, T., McAdam, K., Houston, S., Irwin, M., Pharoah, P., Brenton, J., Walton, N., Earl, H., & Caldas, C. (2016). computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast cancer research, 18(1), 1–11. http://access.bl.uk/ark:/81055/vdc_100080432143.0x000081